Echo Therapeutics Inc (NASDAQ:ECTE)
| 0.58 Data as of May 24 |  +0.03 / +5.45%Today’s Change | 0.18 Today|||52-Week Range 2.00 | -44.23% Year-to-Date |
Latest ECTE News | Press Releases
No recent news for Echo Therapeutics Inc.
Today’s Trading
| Previous close | 0.55 |
| Today’s open | 0.60 |
| Day’s range | 0.56 - 0.61 |
| Volume | 611,119 |
| Average volume (3 months) | 233,592 |
| Market cap | $33.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +36.73% |
| Earnings growth (this year) | -26.88% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -98.86% |
| P/E ratio | NM |
| Price/Sales | 8,035.26 |
| Price/Book | 2.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HEBHemispherx Biopharma... | -0.00 | -0.25% |
| MSTXMast Therapeutics In... | +0.04 | +5.80% |
| CPRXCatalyst Pharmaceuti... | +0.04 | +5.38% |
| IDRAIdera Pharmaceutical... | -0.01 | -2.16% |
Data as of 3:59pm ET, 05/24/2013
Financials
| Next reporting date | August 16, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $5.1K |
| Annual profit (last year) | -$12.3M |
| Net profit margin | -240,906.58% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Patrick T. Mooney, MD |
Senior Vice President- Operations Marshall D. Deweese |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
